D-1083-2020 Class II Terminated

Recalled by PharMEDium Services, LLC — Dayton, NJ

FDA drug recall D-1083-2020 was initiated by PharMEDium Services, LLC on March 16, 2020 and is designated Class II. Reason for recall: Firm is recalling 46 lots of various products because of a lack of sterility assurance. The recall status is terminated (terminated February 14, 2025). Affected quantity: 4625 units.

Recall Details

Product Type
Drugs
Report Date
April 15, 2020
Initiation Date
March 16, 2020
Termination Date
February 14, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4625 units

Product Description

rocuronium Bromide 10 mg per mL 50 mg per 5 mL, 5 mL BD Syringe, For IV Use, PharMEDium 913 N. Davis Ave. Cleveland, MS. Preservative Free, NDC 71019-321-10

Reason for Recall

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Distribution Pattern

Distributed Nationwide in the US

Code Information

193510017D 3/17/2020 193530001D 3/19/2020 193540002D 3/22/2020